Cargando…

The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia

CONTEXT: Early use of a high-flow nasal cannula (HFNC) provides positive outcomes for preventing the risk of intubation. However, the efficiency and usage of HFNC in the case of coronavirus disease 2019 (COVID-19) among adult patients with multiple risk factors remain debatable and require more inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Thaqafy, Majid S., Alzahrani, Saleh, Alghamdi, Abdulwahab, Alselemi, Saleh, Alshebani, Khalid, Bugis, Bussma Ahmed, Bugis, Alaa, Al-Shareef, Ali S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662081/
https://www.ncbi.nlm.nih.gov/pubmed/36387758
http://dx.doi.org/10.4103/atm.atm_156_22
_version_ 1784830614515482624
author Al-Thaqafy, Majid S.
Alzahrani, Saleh
Alghamdi, Abdulwahab
Alselemi, Saleh
Alshebani, Khalid
Bugis, Bussma Ahmed
Bugis, Alaa
Al-Shareef, Ali S.
author_facet Al-Thaqafy, Majid S.
Alzahrani, Saleh
Alghamdi, Abdulwahab
Alselemi, Saleh
Alshebani, Khalid
Bugis, Bussma Ahmed
Bugis, Alaa
Al-Shareef, Ali S.
author_sort Al-Thaqafy, Majid S.
collection PubMed
description CONTEXT: Early use of a high-flow nasal cannula (HFNC) provides positive outcomes for preventing the risk of intubation. However, the efficiency and usage of HFNC in the case of coronavirus disease 2019 (COVID-19) among adult patients with multiple risk factors remain debatable and require more investigation. AIMS: The aim of this study was to determine the efficiency of HFNC in preventing the possible risk of intubation. SETTINGS AND DESIGN: This study was an observational cross-sectional study that was conducted at a selected hospital in Jeddah, Saudi Arabia, from July 2020 to August 2021. METHODS: The data were collected from patients’ medical records through the hospital health information system. Adult COVID-19 patients who used HFNC were included, while those who used bilevel positive airway pressure or continuous positive airway pressure without any trials of HFNC and neonatal or pediatric patients were excluded. The exposure of HFNC setting which included variables such as percentages of the fraction of inspired oxygen and the duration of using HFNC were measured to find the relation with respiratory rate oxygenation (ROX) index as a measurement of patient outcome. STATISTICAL ANALYSIS USED: The data were analyzed by using the online calculator socscistatistics. com for prevalence statistics, and correlation tests of significance. Prevalence statistics were presented in mean, median, frequencies, and percentages. Statistical tests were used to measure correlations of key variables. P < 0.05 of ANOVA and t-tests was considered statistically significant. RESULTS: A total of 159 adult COVID-19 patients using HFNC were included, and most of these patients were male. The median age was 64 years. Most of patients were reported to have hypertension and diabetes mellitus. The majority (94.34%) of patients were successfully weaned from HFNC and shows effective intervention with a mean of 7.53 of ROX score. Appropriate implementation of HFNC might be a successful intervention for preventing the risk of intubation. CONCLUSIONS: According to the success rate of HFNC, which was considered a positive outcome, there might be a promising intervention for HFNC to prevent the risk of intubation and decrease the mortality rate.
format Online
Article
Text
id pubmed-9662081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-96620812022-11-15 The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia Al-Thaqafy, Majid S. Alzahrani, Saleh Alghamdi, Abdulwahab Alselemi, Saleh Alshebani, Khalid Bugis, Bussma Ahmed Bugis, Alaa Al-Shareef, Ali S. Ann Thorac Med Original Article CONTEXT: Early use of a high-flow nasal cannula (HFNC) provides positive outcomes for preventing the risk of intubation. However, the efficiency and usage of HFNC in the case of coronavirus disease 2019 (COVID-19) among adult patients with multiple risk factors remain debatable and require more investigation. AIMS: The aim of this study was to determine the efficiency of HFNC in preventing the possible risk of intubation. SETTINGS AND DESIGN: This study was an observational cross-sectional study that was conducted at a selected hospital in Jeddah, Saudi Arabia, from July 2020 to August 2021. METHODS: The data were collected from patients’ medical records through the hospital health information system. Adult COVID-19 patients who used HFNC were included, while those who used bilevel positive airway pressure or continuous positive airway pressure without any trials of HFNC and neonatal or pediatric patients were excluded. The exposure of HFNC setting which included variables such as percentages of the fraction of inspired oxygen and the duration of using HFNC were measured to find the relation with respiratory rate oxygenation (ROX) index as a measurement of patient outcome. STATISTICAL ANALYSIS USED: The data were analyzed by using the online calculator socscistatistics. com for prevalence statistics, and correlation tests of significance. Prevalence statistics were presented in mean, median, frequencies, and percentages. Statistical tests were used to measure correlations of key variables. P < 0.05 of ANOVA and t-tests was considered statistically significant. RESULTS: A total of 159 adult COVID-19 patients using HFNC were included, and most of these patients were male. The median age was 64 years. Most of patients were reported to have hypertension and diabetes mellitus. The majority (94.34%) of patients were successfully weaned from HFNC and shows effective intervention with a mean of 7.53 of ROX score. Appropriate implementation of HFNC might be a successful intervention for preventing the risk of intubation. CONCLUSIONS: According to the success rate of HFNC, which was considered a positive outcome, there might be a promising intervention for HFNC to prevent the risk of intubation and decrease the mortality rate. Wolters Kluwer - Medknow 2022 2022-10-07 /pmc/articles/PMC9662081/ /pubmed/36387758 http://dx.doi.org/10.4103/atm.atm_156_22 Text en Copyright: © 2022 Annals of Thoracic Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Al-Thaqafy, Majid S.
Alzahrani, Saleh
Alghamdi, Abdulwahab
Alselemi, Saleh
Alshebani, Khalid
Bugis, Bussma Ahmed
Bugis, Alaa
Al-Shareef, Ali S.
The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia
title The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia
title_full The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia
title_fullStr The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia
title_full_unstemmed The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia
title_short The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia
title_sort efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in jeddah, saudi arabia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662081/
https://www.ncbi.nlm.nih.gov/pubmed/36387758
http://dx.doi.org/10.4103/atm.atm_156_22
work_keys_str_mv AT althaqafymajids theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alzahranisaleh theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alghamdiabdulwahab theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alselemisaleh theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alshebanikhalid theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT bugisbussmaahmed theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT bugisalaa theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alshareefalis theefficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT althaqafymajids efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alzahranisaleh efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alghamdiabdulwahab efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alselemisaleh efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alshebanikhalid efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT bugisbussmaahmed efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT bugisalaa efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia
AT alshareefalis efficiencyofhighflownasalcannulaforadultpatientswithcoronavirusdisease19injeddahsaudiarabia